Andrew B. Lassman, MD

Neuro-Oncology
Cancer Care, Neurology
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Andrew B. Lassman, MD, is a Professor of Neurology and Associate Dean of Clinical Trials at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Department of Neurology Division of Neuro-Oncology and Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.

Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.

Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center.

Areas of Expertise / Conditions Treated

  • Acoustic Neuroma
  • Anaplastic Astrocytoma
  • Astrocytoma
  • Brain Cancer
  • Brain Metastases
  • Brain Stem Glioma
  • Brain Tumor
  • Carcinomatous meningitis
  • Chordoma
  • Choroid Plexus Carcinoma
  • Choroid Plexus Papilloma
  • Ependymoma
  • Glioblastoma
  • Glioblastoma Multiforme
  • Gliomas
  • Hemangioblastoma
  • Leptomeningeal metastases
  • Medulloblastoma
  • Meningioma
  • Metastatic Cancer
  • Mixed Glioma
  • Neurofibromatosis
  • Oligoastrocytoma
  • Oligodendroglioma
  • Second Opinion
  • Spinal Cord Tumor
  • Spine Tumors

Academic Appointments

  • John Harris Professor of Neurology at the Columbia University Medical Center

Administrative Titles

  • Chief, Division of Neuro-Oncology
  • Associate Director for Clinical Trials, Herbert Irving Comprehensive Cancer Center
  • Associate Dean of Clinical Research Compliance, Vagelos College of Physicians & Surgeons, Columbia University
  • Scientific Director, Network Capacity Resource, Irving Institute for Clinical & Translational Research

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

710 West 168th Street
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • NY Signature
  • POS

Affinity Health Plan

  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Quality Health Management

  • Quality Health Management

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty
  • POS
  • PPO

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care
  • New Jersey Services (Medicaid Managed Care)

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, 1997 Columbia University College of Physicians and Surgeons
  • Internship: 1998 Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital Program, New York, NY
  • Residency: 2001 NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
  • Fellowship: 2003 Memorial Sloan-Kettering Cancer Center, New York, NY

Committees, Societies, Councils

American Medical Association, Member

American Academy of Neurology, Member

Society for Neuro-Oncology, Member

American Society of Clinical Oncology, Member

Radiation Therapy Oncology Group, Brain Committee

Society for Neuro-Oncology, Annual Meeting, Abstract Review Committee

NIH Common Terminology Criteria for Adverse Events (CTCAE) Revision Committee

United Council for Neurologic Subspecialties Board, Neuro-Oncology Representative

Voices Against Brain Cancer Medical Advisory Board

American Society of Clinical Oncology, Scientific Program Committee, CNS Track

American College of Radiation Oncology, Scientific Program Committee

 

Board Certifications

  • Neurology

Honors & Awards

  1. Clinician of the Year, Neurology, Columbia University Irving Medical Center, 2022
  2. Nobility in Science Award, Oligo Nation, 2021
  3. Fellow of the American Academy of Neurology (FAAN), 2020
  4. Adult Clinical Research Abstract Award, Society for Neuro-Oncology, 2019
    For excellence in adult clinical research (1 recipient annually)
  5. America’s Top Doctors for Cancer, Castle Connolly, 2016-present
  6. Top Doctors, New York Magazine, 2013-present
  7. Gary Lichtenstein Humanitarian Award, Voices Against Brain Cancer, 2012
  8. John Harris Associate Professorship of Neurology, 2012-present
    Columbia University in the City of New York
  9. Boyer Clinical Research Award, Memorial Sloan Kettering Cancer Center, 2010
    For outstanding research accomplishments under the age of 40
    (1 recipient annually)
  10. Preuss Award in Neuro-Oncology, American Academy of Neurology, 2008
    For demonstrating exceptional commitment and potential in clinical neuro-oncology research and to recognize important and relevant clinical advances in the discipline
    (1 recipient annually)
  11. Neurology Resident Teaching Award, 2004-05, 10-11
    Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
  12. Chief Fellow, Neuro-Oncology, Memorial Sloan Kettering Cancer Center, 2002-03
    (1 annually)
  13. Phi Beta Kappa, Yale University, 1992 
America's Top Doctor
NY Top Doctor

Research

Dr. Lassman's research interests focus on translational clinical trials for brain tumors with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms.

Research Interests

  • Brain and leptomeningeal metastases
  • Translational clinical trials for brain tumors

Clinical Trials

Multiple clinical trials for patients with brain tumors metastases